Why Cameco Could Be One of the Biggest Winners in America's Nuclear Renaissance

Cameco, the world’s second-largest uranium producer (about 17% of global output), reported Q3 2025 revenue down 15% year-over-year to $441.7M with a small loss per share and a 5% EBITDA decline driven by production issues, but is on track to meet 2025 deliveries. For the first nine months of 2025 revenue rose 17%, EBITDA climbed 33% and EPS jumped 203%, while uranium production was up 2% in the quarter; the company’s high-grade Canadian reserves (McArthur River/Key Lake 6.55%, Cigar Lake 15.87%) plus a 49% stake in Westinghouse position it to benefit from an $80B U.S. plan to build AP1000 reactors, U.S. limits on Russian uranium, and favorable tariff carve-outs for Canadian energy exports. The combination of strong YTD performance (stock +60% YTD), strategic vertical integration, and sizable U.S. government-backed reactor spending supports a bullish long-term thesis despite the near-term quarterly setback.

Analysis

Market structure: Vertical-integrated producers with secure high‑grade feedstock and fabrication stakes (producers, fuel fabricators, select services) are positioned to capture contract repricing and margin expansion as governments underwrite reactor builds. Expect incremental pricing power over 12–36 months as long lead times and conversion bottlenecks constrain supply elasticity; CAD should see modest support vs. USD on sustained Canadian export demand, while industrial cyclicals tied to reactor construction outperform utilities that lack fuel security.

Risk assessment: Key tail risks include policy reversals or permit/licensing delays that can wipe out multi‑year revenue trajectories, major operational incidents at a large mine, or a surge in secondary/Russian substitution that depresses spot prices by >30% within 12 months. Immediate risk (days) is headline volatility around delivery/production miss; medium (3–9 months) hinges on DOE contract awards and tariff rulings; long term (2–5 years) depends on actual AP1000 build cadence and supply chain localization.

Trade implications: Favor concentrated, size‑controlled exposure to established producers (ticker CCJ) and select industrial suppliers (e.g., BWXT) while avoiding pure exploration juniors; use 12–24 month time horizons and layer in on 10–20% pullbacks. Employ relative value: long integrated producer vs. short high‑beta exploration names to capture de‑risking and funding constraints; use call spreads to express convexity with capped premium outlay.

Contrarian angles: Consensus underestimates schedule slippage and capital intensity—markets may be pricing in ideal funding flow rather than execution risk, creating a potential re-rating if DOE awards are delayed past 6–12 months. Historical parallels (prior uranium cycles) show spot spikes often reverse once secondary supplies re-enter, so downside of 25–40% exists if multi‑year contracting stalls; insiders’ operational execution and contract pipeline disclosure will be the true discriminators.

Key Decisions for Investors

• Establish a 3% portfolio long position in CCJ over the next 4 weeks, scale in 50/30/20 across three buys; add an extra 1–2% if CCJ drops >15% from entry. Target 18–24 month hold; trim half at +40% and exit remainder at +80% or if shares fall 25% from cost.
• Implement a pair trade: Long CCJ (2% weight) and short NXE (NexGen, 1% weight) to capture value difference between integrated producer and greenfield explorer; rebalance if spread narrows by 50% or after 12 months.
• Buy CCJ 12–15 month call spread (buy ATM call, sell 35% OTM call) sized to 0.5–1.0% of portfolio notional to express upside while limiting premium; enter within 8 weeks and roll only if DOE contract awards materially change (see next item).
• Monitor three catalysts on 30/90/180‑day cadence and act decisively: (a) DOE/U.S. contract awards >$2B to domestic fuel or fabrication within 90 days — increase CCJ exposure by 1–2%; (b) absence of material awards at 180 days — reduce CCJ exposure by half; (c) any major mine incident or permit reversal — cut exposure to zero.